BE897085A - Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication - Google Patents

Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication Download PDF

Info

Publication number
BE897085A
BE897085A BE0/211031A BE211031A BE897085A BE 897085 A BE897085 A BE 897085A BE 0/211031 A BE0/211031 A BE 0/211031A BE 211031 A BE211031 A BE 211031A BE 897085 A BE897085 A BE 897085A
Authority
BE
Belgium
Prior art keywords
sep
pyridazinone
compounds according
new
choh
Prior art date
Application number
BE0/211031A
Other languages
English (en)
French (fr)
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Publication of BE897085A publication Critical patent/BE897085A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE0/211031A 1982-06-18 1983-06-17 Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication BE897085A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Publications (1)

Publication Number Publication Date
BE897085A true BE897085A (fr) 1983-12-19

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/211031A BE897085A (fr) 1982-06-18 1983-06-17 Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication

Country Status (10)

Country Link
JP (1) JPS5910571A (de)
KR (1) KR860001339B1 (de)
BE (1) BE897085A (de)
CH (1) CH657125B (de)
DE (1) DE3321772A1 (de)
FR (1) FR2528837A1 (de)
GB (1) GB2122195A (de)
GR (1) GR78284B (de)
IT (1) IT1194281B (de)
NL (1) NL8302087A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
JPS63220512A (ja) * 1987-03-09 1988-09-13 松下電器産業株式会社 電解コンデンサ用電極箔
JPH04100106U (de) * 1991-02-12 1992-08-28
JPH0776050B2 (ja) * 1991-07-25 1995-08-16 実 近藤 ワークの移送装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Also Published As

Publication number Publication date
CH657125B (de) 1986-08-15
KR860001339B1 (ko) 1986-09-15
IT1194281B (it) 1988-09-14
NL8302087A (nl) 1984-01-16
DE3321772A1 (de) 1983-12-22
IT8321684A0 (it) 1983-06-17
FR2528837A1 (fr) 1983-12-23
JPS5910571A (ja) 1984-01-20
FR2528837B1 (de) 1984-12-07
GR78284B (de) 1984-09-26
GB8316516D0 (en) 1983-07-20
KR840005105A (ko) 1984-11-03
GB2122195A (en) 1984-01-11

Similar Documents

Publication Publication Date Title
EP0097071A1 (de) Benzhydrylsulfinylacetamid-Derivate und deren Verwendung in der Therapeutik
EP0352301A1 (de) Buttersäure-ester und ihre verwendung als arzneimittel
FR2525601A1 (fr) Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
BE897085A (fr) Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication
EP0138721A2 (de) Benzensulfonyllactame, Verfahren zu ihrer Herstellung und ihre Anwendung als wirksame Bestandteile in pharmazeutischen Zusammensetzungen
CH628032A5 (fr) Procede de preparation de derives de prostaglandine.
EP0366511A1 (de) Benzoxazolinon-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
EP0239436B1 (de) Tricyclisches Derivat, nämlich 5-(3-Chloro-6-methyl-5,5-dioxo-6,11-dihydro-dibenzo[c,f] [1,2]-thiazepin-11-yl amino)-pentansäure, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
EP0076755B1 (de) Acylamino-4-aza-1-adamantane, Verfahren zu ihrer Herstellung und ihre Anwendung in der Therapeutik
EP0001021B1 (de) Derivate pentacyclischer Alkaloide, Verfahren zu deren Herstellung, Anwendung für die Synthese von Produkten der Eburnamoningruppe und pharmazeutische Zusammensetzungen
FR2527206A1 (fr) Nouveaux derives de la 2(1h)-pyridinone, leur preparation et leur utilisation comme medicaments
FR2577552A1 (fr) Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique
FR2489318A1 (fr) Sel d'acide((1-benzyl-1h-indazol-3-yl)oxy)acetique avec la lysine
EP0094283B1 (de) Arzneimittelform von Theophyllin mit verlängerter Wirkung
EP0035945B1 (de) Acylguanidine, Harnstoffe und substituierte Harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO1981002295A1 (fr) Phenoxyisobutyrates de moroxydine et medicaments les contenant
EP0143711A2 (de) Derivate von N-(Methoxyphenacyl)aminen, ihre therapeutische Verwendung und Verfahren zu ihrer Herstellung
FR2636065A1 (fr) Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
FR2518537A1 (fr) Nouveaux derives de l'acide phenylacetique, leur preparation et compositions les contenant
FR2463141A1 (fr) Nouveaux derives de 10-halo-e-homoeburnane, procede de preparation de ces nouveaux derives et medicaments les contenant
FR2526793A1 (fr) Nouveaux a-(n-pyrrolyl)-acides et leurs sels et esters, utiles comme medicaments et procede de la preparation de tels composes
EP0082040B1 (de) 3,7a-Diazacyclohepta(j,k)fluorenderivate, ihre Herstellung und ihre therapeutische Verwendung
FR2564462A1 (fr) Derives de la 2-phenyl-morpholine utiles en therapeutique
FR2486074A1 (fr) Derives de fluorophenacyl-amine, leur procede de preparation et leur application en therapeutique
CH618977A5 (de)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: THEA THERAPEUTIQUE ET APPLICATIONS S.A.

Effective date: 19890630